Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Gobom

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 7, 2026
Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-oldsAnna Dittrich, Burak Arslan, Tobias Skillbäck, et al.
Protein Science : a Publication of the Protein Society|March 9, 2006
Crystal structure of Homo sapiens PTD012 reveals a zinc-containing hydrolase foldBabu A Manjasetty, Konrad Büssow, Martin Fieber-Erdmann, et al.
Electrophoresis|March 1, 2002
Generation of minimal protein identifiers of proteins from two-dimensional gels and recombinant proteinsFrank Schmidt, Angelika Lueking, Eckhard Nordhoff, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|December 17, 2021
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's diseaseKarl Hansson, Rahil Dahlén, Oskar Hansson, et al.
Journal of Proteome Research|January 6, 2007
Multidimensional chromatography: a powerful tool for the analysis of membrane proteins in mouse brainChristiane Lohaus, Andreas Nolte, Martin Blüggel, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|October 3, 2022
Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82]Karl Hansson, Rahil Dahlén, Oskar Hansson, et al.
Clinical Chemistry|May 21, 2014
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluidAndreas Leinenbach, Josef Pannee, Thomas Dülffer, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's diseaseErik Portelius, Maria Olsson, Gunnar Brinkmalm, et al.
Journal of Proteome Research|December 10, 2014
An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseMikko Hölttä, Lennart Minthon, Oskar Hansson, et al.
Fluids and Barriers of the CNS|June 5, 2023
Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalusSophia Weiner, Antti Junkkari, Mathias Sauer, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 7, 2026
Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-oldsAnna Dittrich, Burak Arslan, Tobias Skillbäck, et al.
Protein Science : a Publication of the Protein Society|March 9, 2006
Crystal structure of Homo sapiens PTD012 reveals a zinc-containing hydrolase foldBabu A Manjasetty, Konrad Büssow, Martin Fieber-Erdmann, et al.
Electrophoresis|March 1, 2002
Generation of minimal protein identifiers of proteins from two-dimensional gels and recombinant proteinsFrank Schmidt, Angelika Lueking, Eckhard Nordhoff, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|December 17, 2021
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's diseaseKarl Hansson, Rahil Dahlén, Oskar Hansson, et al.
Journal of Proteome Research|January 6, 2007
Multidimensional chromatography: a powerful tool for the analysis of membrane proteins in mouse brainChristiane Lohaus, Andreas Nolte, Martin Blüggel, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|October 3, 2022
Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82]Karl Hansson, Rahil Dahlén, Oskar Hansson, et al.
Clinical Chemistry|May 21, 2014
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluidAndreas Leinenbach, Josef Pannee, Thomas Dülffer, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's diseaseErik Portelius, Maria Olsson, Gunnar Brinkmalm, et al.
Journal of Proteome Research|December 10, 2014
An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseMikko Hölttä, Lennart Minthon, Oskar Hansson, et al.
Fluids and Barriers of the CNS|June 5, 2023
Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalusSophia Weiner, Antti Junkkari, Mathias Sauer, et al.
Pageof 14